Cipla Share Price

Cipla Overview

Cipla Limited was founded in 1935 by Khwaja Abdul Hamied and incorporated under its present name in 1984. Headquartered in Mumbai, Maharashtra, the company is listed on both NSE (CIPLA) and BSE (500087). It is a global pharmaceutical major focused on developing, manufacturing, and marketing generic and branded medicines across areas such as respiratory, cardiovascular, anti-retroviral, oncology, and consumer healthcare, both in India and internationally.

Cipla Business Segments and Revenue Model

Cipla operates through key verticals: Generic Pharmaceuticals, Branded Pharmaceuticals, Active Pharmaceuticals Ingredients (API), Specialty Therapies (including oncology and respiratory), and Consumer Healthcare. It generates revenue through the sale of pharmaceutical products to hospitals, clinics, and retailers, as well as through exports. Net interest income, though minimal, comes from its treasury investments. Its diverse global presence in markets like the US, Africa, and Europe ensures balanced revenue, with R&D-led specialty products enhancing margins alongside scale-driven generics.

Cipla Key Milestones

• 1935: Founded in Mumbai as Chemical, Industrial & Pharmaceutical Laboratories
• 1984: Renamed Cipla Limited
• 1995: Launched Deferiprone, the world’s first oral iron chelator
• 2006: Acquired remdesivir licence, launched Cipremi in India
• 2013: Acquired Cipla-Medpro (South Africa)
• 2015: Acquired U.S. generics firms InvaGen and Exelan for $555 million
• 2019: Ventured into digital therapeutics via partnerships in India and South Africa
• 2023: Acquired cosmetics distribution business of Ivia Beaute for ₹130 crore
• May 2025: Announced a combined ₹16/share dividend to mark its 90th anniversary

Cipla ESG and Sustainability

• CSR focus includes access to healthcare, education, women’s empowerment, and community health initiatives
• ESG mission emphasises strengthening healthcare access globally and reducing environmental impact through sustainable manufacturing and energy efficiency
• Long-term goal to align with global sustainability benchmarks and foster inclusive growth

Cipla Awards and Recognitions

• Thomson Reuters India Innovation Award (2012)
• Featured in Forbes “200 Best Under a Billion” list (2007)
• Chemexcil Award for excellence in exports (1980)
• Consistently recognised for innovation, quality, and corporate governance